Altered Expression of CDC42 Signaling Pathway Components in Cortical Layer 3 Pyramidal Cells in Schizophrenia
暂无分享,去创建一个
J. Corradi | D. Datta | D. Arion | D. Lewis
[1] D. Volk,et al. Chemokine receptors and cortical interneuron dysfunction in schizophrenia , 2015, Schizophrenia Research.
[2] J. Kleinman,et al. Free Paper , 2015 .
[3] D. Datta,et al. Developmental Expression Patterns of GABAA Receptor Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal Cortex. , 2015, Cerebral cortex.
[4] J. Coyle,et al. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. , 2014, JAMA psychiatry.
[5] Aiqing He,et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder , 2014, Molecular Psychiatry.
[6] T. Joshi,et al. An association analysis between psychophysical characteristics and genome-wide gene expression changes in human adaptation to the extreme climate at the Antarctic Dome Argus , 2014, Molecular Psychiatry.
[7] H. Bazmi,et al. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. , 2014, The American journal of psychiatry.
[8] Peilin Jia,et al. Transcriptome Sequencing and Genome-wide Association Analyses Reveal Lysosomal Function and Actin Cytoskeleton Remodeling in Schizophrenia and Bipolar Disorder , 2014, Molecular Psychiatry.
[9] David W. Nauen,et al. Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. , 2014, Cell stem cell.
[10] H. Kasai,et al. PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence , 2014, Proceedings of the National Academy of Sciences.
[11] G. López-Doménech,et al. The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines , 2014, Translational Psychiatry.
[12] E. Banks,et al. De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.
[13] D. Lewis,et al. Dendritic spine pathology in schizophrenia , 2013, Neuroscience.
[14] K. Shen,et al. Cellular and molecular mechanisms underlying presynapse formation , 2013, The Journal of cell biology.
[15] R. Kahn,et al. Schizophrenia is a cognitive illness: time for a change in focus. , 2013, JAMA psychiatry.
[16] A. Egerton,et al. Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis , 2013, Front. Psychiatry.
[17] A. Koleske. Molecular mechanisms of dendrite stability , 2013, Nature Reviews Neuroscience.
[18] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[19] T M Hyde,et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia , 2013, Molecular Psychiatry.
[20] A. Arnsten,et al. Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses , 2012, Neuron.
[21] Danko D. Georgiev,et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. , 2012, The American journal of psychiatry.
[22] V. Haroutunian,et al. Abnormalities of the Duo/Ras-Related C3 Botulinum Toxin Substrate 1/p21-Activated Kinase 1 Pathway Drive Myosin Light Chain Phosphorylation in Frontal Cortex in Schizophrenia , 2012, Biological Psychiatry.
[23] G. Tseng,et al. Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: With application to major depressive disorder , 2012, BMC Bioinformatics.
[24] David A. Lewis,et al. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia , 2012, Trends in Neurosciences.
[25] Z. J. Huang,et al. Cortical Glutamic Acid Decarboxylase 67 Deficiency Results in Lower Cannabinoid 1 Receptor Messenger RNA Expression: Implications for Schizophrenia , 2012, Biological Psychiatry.
[26] Akira Sawa,et al. Linking neurodevelopmental and synaptic theories of mental illness through DISC1 , 2011, Nature Reviews Neuroscience.
[27] Vahram Haroutunian,et al. Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia , 2011, Biological Psychiatry.
[28] A. Sampson,et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. , 2011, The American journal of psychiatry.
[29] J. Glausier,et al. Selective Pyramidal Cell Reduction of GABAA Receptor α1 Subunit Messenger RNA Expression in Schizophrenia , 2011, Neuropsychopharmacology.
[30] Jia Li,et al. An adaptively weighted statistic for detecting differential gene expression when combining multiple transcriptomic studies , 2011, 1108.3180.
[31] Ryohei Yasuda,et al. Local, persistent activation of Rho GTPases during plasticity of single dendritic spines , 2011, Nature.
[32] D. Volk,et al. Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. , 2010, The American journal of psychiatry.
[33] David A. Lewis,et al. Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits , 2010, Biological Psychiatry.
[34] C. Hoogenraad,et al. Actin in dendritic spines: connecting dynamics to function , 2010, The Journal of cell biology.
[35] David A Lewis,et al. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. , 2008, The American journal of psychiatry.
[36] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.
[37] K. Mikoshiba,et al. Pak1 regulates dendritic branching and spine formation , 2007, Developmental neurobiology.
[38] K. Mirnics,et al. Molecular markers distinguishing supragranular and infragranular layers in the human prefrontal cortex , 2007, The European journal of neuroscience.
[39] R. Scott,et al. LIM kinases: function, regulation and association with human disease , 2007, Journal of Molecular Medicine.
[40] J. Meador-Woodruff,et al. NMDA receptors and schizophrenia. , 2007, Current opinion in pharmacology.
[41] C. Tamminga,et al. Regional alterations in RGS4 protein in schizophrenia , 2006, Synapse.
[42] T. Hashimoto,et al. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia , 2006, Molecular Psychiatry.
[43] Daniel R Weinberger,et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.
[44] J. Bamburg,et al. Cdc42 participates in the regulation of ADF/cofilin and retinal growth cone filopodia by brain derived neurotrophic factor. , 2006, Journal of neurobiology.
[45] M. Sheng,et al. Molecular mechanisms of dendritic spine morphogenesis , 2006, Current Opinion in Neurobiology.
[46] Maryann E Martone,et al. Transient decrease in F‐actin may be necessary for translocation of proteins into dendritic spines , 2005, The European journal of neuroscience.
[47] Zhuoxin Sun,et al. The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.
[48] L. Van Aelst,et al. Rho GTPases, dendritic structure, and mental retardation. , 2005, Journal of neurobiology.
[49] H. Katoh,et al. Rho Family GTPases and Dendrite Plasticity , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[50] David A Lewis,et al. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.
[51] D. Webb,et al. A GIT1/PIX/Rac/PAK Signaling Module Regulates Spine Morphogenesis and Synapse Formation through MLC , 2005, The Journal of Neuroscience.
[52] P. Lappalainen,et al. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. , 2004, Molecular biology of the cell.
[53] J. Coyle. The GABA-glutamate connection in schizophrenia: which is the proximate cause? , 2004, Biochemical pharmacology.
[54] A. Sampson,et al. Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits , 2004, Biological Psychiatry.
[55] Bita Moghaddam,et al. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia , 2004, Psychopharmacology.
[56] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[57] David A Lewis,et al. Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with Schizophrenia , 2003, Neuropsychopharmacology.
[58] Stephan Heckers,et al. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. , 2003, Pharmacology & therapeutics.
[59] Rafael Yuste,et al. Spine Motility Phenomenology, Mechanisms, and Function , 2002, Neuron.
[60] T. Haystead,et al. Borg proteins control septin organization and are negatively regulated by Cdc42 , 2001, Nature Cell Biology.
[61] A. Sampson,et al. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.
[62] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[63] Toshikazu Nakamura,et al. Specific Activation of LIM kinase 2 via Phosphorylation of Threonine 505 by ROCK, a Rho-dependent Protein Kinase* , 2001, The Journal of Biological Chemistry.
[64] L. Luo. RHO GTPASES in neuronal morphogenesis , 2000, Nature Reviews Neuroscience.
[65] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[66] Gregory R. Hoffman,et al. Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI , 2000, Cell.
[67] Y. Takai,et al. Cofilin Phosphorylation and Actin Cytoskeletal Dynamics Regulated by Rho- and Cdc42-Activated Lim-Kinase 2 , 1999, The Journal of cell biology.
[68] D. C. Edwards,et al. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics , 1999, Nature Cell Biology.
[69] S. Hirsch,et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[70] P. Goldman-Rakic,et al. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.
[71] P. Chavrier,et al. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity , 1998, FEBS letters.
[72] J. Trojanowski,et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. , 1995, The American journal of psychiatry.
[73] L. Lim,et al. A brain serine/threonine protein kinase activated by Cdc42 and Rac1 , 1994, Nature.
[74] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[75] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[76] A. Sampson,et al. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. , 2015, Schizophrenia bulletin.
[77] Wei Zhang,et al. Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.
[78] Maria Carla Parrini,et al. Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. , 2002, Molecular cell.
[79] L. Glantz,et al. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.
[80] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .